Kekec Ahmet, Tran Lauren My-Linh, Plummer Christopher W, Kalyani Dipannita
Discovery Chemistry, Merck & Co., Inc. Rahway New Jersey 07065 USA
Chem Sci. 2025 Jan 6;16(5):2287-2294. doi: 10.1039/d4sc06837h. eCollection 2025 Jan 29.
This manuscript describes a strategy to readily access diverse aryl and homoaryl alanine-containing pharmaceutically relevant macrocyclic peptides. A two-step sequence involving the late-stage installation of the pyridinium functionality on macrocyclic peptides followed by reductive couplings was implemented. These transformations are amenable to microscale high-throughput experimentation (HTE) and enable rapid access to aryl alanine-containing macrocyclic peptides that would otherwise be inaccessible solid-phase peptide synthesis using commercially available amino acids. Numerous aryl and heteroaryl derivatives can be effectively used in these reactions. In addition, a systematic investigation was undertaken using an "informer" set of macrocyclic peptides which revealed the compatibility of the late-stage diversification with peptides containing diverse side chain functionalities.
本手稿描述了一种可轻松获得多种含芳基和同芳基丙氨酸的药学相关大环肽的策略。实施了两步序列,包括在大环肽上后期安装吡啶鎓官能团,然后进行还原偶联。这些转化适用于微量高通量实验(HTE),并能够快速获得含芳基丙氨酸的大环肽,否则使用市售氨基酸通过固相肽合成无法获得这些大环肽。许多芳基和杂芳基衍生物可有效地用于这些反应。此外,使用一组“告知者”大环肽进行了系统研究,结果表明后期多样化与含有不同侧链官能团的肽具有兼容性。